Overview

A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of FTY720 on the lung function of patients with moderate asthma
Phase:
Phase 2
Details
Lead Sponsor:
Novartis
Treatments:
Fingolimod Hydrochloride